Sincalide

Sincalide
Product Description

Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.


Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    Price; Product Features; Product Performance; Quality Service
  • Supplied from
    India
  • Measured In
    gram; kilogram

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator

More Products from Biophore Pharma INC. (57)

  • Gadobenate dimeglumine

    Product Gadobenate dimeglumine

    Gadobenate dimeglumine is an Diagnostic Agent which is indicated for the  treatment of Magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults.


    Biophore's Gadobenate dimeglumine: API Developed, Stringent control on inorganic impurities, ...
  • Gadobutrol

    Product Gadobutrol

    Gadobutrol is an MRI Contrast Agent.

    Biophore's Gadobutrol:  Product meets the specifications of the EP draft monograph,  All impurities below 0.05, Stringent control on sodium and chloride. 
  • Liothyronine Sodium

    Product Liothyronine Sodium

    Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.

    Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed


  • Methazolamide

    Product Methazolamide

    Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
    Biophore's Methazolamide: 
  • Nadolol

    Product Nadolol

    Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.


    Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016.
  • Palbociclib

    Product Palbociclib

    Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2. 

  • Zofenopril

    Product Zofenopril

    Zofenopril is an Antihypertensive agent.

    Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed  [ # 026446 ].
  • Tipiracil

    Product Tipiracil

    Tipiracil is an Thymidine  phosphorylase inhibitor/nucleoside metabolic inhibitor used to treatment of metastatic colorectal cancer.
  • Trifluridine

    Product Trifluridine

    Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis.
  • DOTA

    Product DOTA

    DOTA is an Chelating agent

    Biophore's DOTA:   All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe.
  • DTPA

    Product DTPA

    DTPA is an Chelating agent

    Biophore's DTPA: Stringent control on Iron content,  All impurities below 0.01
  • Trientine

    Product Trientine

    Trientinen is indicated for the treatment of  patients with Wilson's disease who are intolerant of penicillamine.

    Biophore's Trientine: DMF Filed

Biophore Pharma INC. resources (1)